Clinical Practice

Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.

Illustration of the pituitary gland beneath the brain with dopamine signals, representing antipsychotic hyperprolactinemia

Clinical Practice

Antipsychotic Hyperprolactinemia: A PMHNP Protocol

A step-by-step PMHNP protocol for antipsychotic hyperprolactinemia: who to screen, the 4-lab workup, when to image, and when adding 5 mg aripiprazole works.

October 5, 2026 Read More →

Selegiline transdermal patch delivering medication through skin layers toward the brain

Clinical Practice

Selegiline Patch for TRD: A PMHNP Prescribing Protocol

The selegiline patch (EMSAM) is the MAOI with no diet rules at 6 mg. A PMHNP protocol for candidates, washouts, dosing, tyramine, and monitoring in TRD.

October 1, 2026 Read More →

Benzodiazepine taper protocol illustration: shrinking pill-shaped steps descending to an open doorway

Clinical Practice

Benzodiazepine Taper Protocol: 2026 PMHNP Guide

A benzodiazepine taper protocol for PMHNPs built on the 2025 joint guideline: 5-10% cuts every 2-4 weeks, when to pause, and how to get through the last steps.

September 24, 2026 Read More →

Clinical desk with a reference binder and stethoscope representing perinatal psychopharmacology decision-making for PMHNPs

Clinical Practice

Perinatal Psychopharmacology: PMHNP Protocol 2026

Perinatal psychopharmacology for PMHNPs: which SSRI to start, how lamotrigine clearance shifts by trimester, lactation RID numbers, and when to escalate.

September 21, 2026 Read More →

Bright light therapy panel glowing on a clinic desk beside morning coffee and a sunrise window

Clinical Practice

Bright Light Therapy: A PMHNP Prescribing Protocol

In a 2016 JAMA Psychiatry trial, bright light beat fluoxetine alone for nonseasonal depression. A PMHNP protocol for dose, timing, bipolar safety, screening.

September 10, 2026 Read More →

Balance scale with salt crystals on one pan and water droplets weighing down the other beside an antidepressant capsule, representing SSRI-induced hyponatremia

Clinical Practice

SSRI Hyponatremia: A PMHNP Sodium Monitoring Protocol

SSRI hyponatremia risk peaks in week one. A PMHNP protocol for who needs a baseline sodium, when to recheck, and what to do at each level once it drops.

September 10, 2026 Read More →

Ascending lamotrigine tablet doses beside a pill organizer illustrating slow titration

Clinical Practice

Lamotrigine Rash: A 2026 PMHNP Titration Protocol

Slow lamotrigine titration cuts serious rash risk from 1 in 100 to about 1 in 2,500. A PMHNP protocol for dosing, interactions, rash triage, and restarts.

August 27, 2026 Read More →

Editorial still-life of a small unbranded plain glass medical vial with a smooth metallic crimp top standing upright on a quiet pale clinical countertop representing a long-acting injectable antipsychotic formulation, a small unbranded plain disposable syringe with a sheathed needle resting flat horizontally beside the vial representing the injection itself, a small shallow round amber-tinted glass dish to the side holding three small smooth round white tablets representing the tapering oral antipsychotic overlap, a small simple sealed brushed-metal sharps container in the background representing safe injection practice, and a small ruled cream paper notepad in the foreground with a thin black fountain pen resting diagonally across it representing the PMHNP transition protocol notes — header illustration for a 2026 PMHNP clinical-practice guide on switching patients from oral antipsychotics to long-acting injectables.

Clinical Practice

LAI Antipsychotics: 2026 PMHNP Transition Protocol

PMHNP step-by-step protocol for switching oral antipsychotics to long-acting injectables in 2026: aripiprazole, paliperidone, risperidone overlap.

June 2, 2026 Read More →

Editorial still-life of a small smooth empty amber prescription bottle standing upright on a quiet wooden bedside table at evening representing prazosin prescribed for PTSD nightmares, a small simple analog desk clock viewed from the front showing late evening hours representing bedtime dosing, a soft folded woven cream wool blanket draped lightly across one corner of the table representing restorative sleep, a small bedside reading lamp casting a warm focused circle of light from above creating a calm pool of light on the table, and a small closed ruled cream paper sleep journal with a thin black fountain pen resting diagonally across it representing nightmare-frequency tracking — header illustration for a 2026 PMHNP clinical guide on the prazosin titration protocol for PTSD-related nightmares.

Clinical Practice

Prazosin for PTSD Nightmares: 2026 PMHNP Titration Protocol

85% of patients on prazosin for PTSD nightmares are underdosed. The 2026 PMHNP titration ladder, sex-specific target doses, and orthostatic safety floor.

May 22, 2026 Read More →

Editorial still-life of a small wooden chair viewed from the side with a smooth river stone resting on its seat representing the inability to sit still, a small analog pocket watch with a thin chain resting beside the chair representing the slow ticking time patients feel during akathisia, a small unmarked closed manila chart folder resting flat behind the chair, and a ceramic mug of warm tea with gentle steam on a quiet wooden desk in soft natural side light — header illustration for a 2026 PMHNP clinical-practice decision tree on antipsychotic-induced akathisia management.

Clinical Practice

Akathisia Management: 2026 PMHNP Decision Tree

Akathisia gets misread as anxiety in up to half of cases. The 2026 PMHNP decision tree: BARS scoring, mirtazapine vs. propranolol, what to never miss.

May 19, 2026 Read More →

Clinical Practice

Join the Fellowship today.